Compare Crispr Therapeutics AG (CRSP) vs Marathon Digital Holdings Inc (MARA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crispr Therapeutics AG vs Marathon Digital Holdings Inc — how do they compare? Crispr Therapeutics AG trades at $53.39 (market cap $4.88B), while Marathon Digital Holdings Inc trades at $9.65 (market cap $3.83B). The key difference: Crispr Therapeutics AG is the larger of the two by market cap, and Crispr Therapeutics AG is trading nearer its 52-week high, Marathon Digital Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Crispr Therapeutics AG for 77 Days and Marathon Digital Holdings Inc for 22 Days on average.
| CRSP | MARA | |
|---|---|---|
Market Cap | $4.88B | $3.83B |
Volume | 2,861,747 | 47,742,698 |
Sector | Health | Financials |
52-Week High | $73.97 | $22.84 |
52-Week Low | $44.34 | $6.73 |
Typical Hold Time | 77 Days | 22 Days |
Enterprise Value | $3.30B | $5.87B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRISPR Therapeutics (CRSP) trades at $50.44, down 3.65% on the day, reflecting a bearish technical trend amid weak financials. The company reported no revenue in 2025, with a net loss of $581.60M and negative profit margins, though it beat Q2 2026 EPS estimates. Analyst consensus remains bullish with a $67.83 price target, while recent news highlights upcoming clinical data readouts for its gene-editing therapies as potential catalysts.
The outlook hinges on pipeline execution, with key data expected by end-2026, but high cash burn and lack of revenue pose significant risks. Upside depends on successful clinical outcomes and commercialization of CASGEVY, while downside risks include trial failures and sustained losses.
MARA trades at $9.91, down 4.34% today, with a bearish technical outlook despite some oversold RSI readings. The company faces severe profitability challenges with a net income margin of -429.71% and negative cash flow from operations of $802.73M in 2025. Recent earnings misses and declining revenue from $907M in 2025 to $804M in 2026 highlight operational struggles, though analyst consensus remains divided with a $13 price target.
The stock presents high risk due to persistent losses and negative cash generation, offset by potential upside if operational efficiency improves. Investors face volatility from Bitcoin sector exposure and regulatory uncertainty, requiring careful risk assessment despite Wall Street's mixed but leaning positive ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →About Marathon Digital Holdings Inc
Marathon Digital Holdings, Inc. is one of the largest publicly traded Bitcoin mining companies in North America. The company focuses on building and operating large-scale, cost-efficient Bitcoin mining facilities. Marathon's strategy centers on increasing its mining hash rate and using sustainable energy sources to expand its Bitcoin production. The company's performance is closely tied to the price of Bitcoin and the overall health of the digital asset mining industry.
Read more on MARA →
